Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Share-based Compensation: 2020-2022

Historic Share-based Compensation for Legend Biotech (LEGN) over the last 3 years, with Dec 2022 value amounting to $34.3 million.

  • Legend Biotech's Share-based Compensation fell 0.64% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.8 million, marking a year-over-year decrease of 4.65%. This contributed to the annual value of $34.3 million for FY2022, which is 70.34% up from last year.
  • As of FY2022, Legend Biotech's Share-based Compensation stood at $34.3 million, which was up 70.34% from $20.2 million recorded in FY2021.
  • In the past 5 years, Legend Biotech's Share-based Compensation registered a high of $34.3 million during FY2022, and its lowest value of $4.8 million during FY2020.
  • In the last 3 years, Legend Biotech's Share-based Compensation had a median value of $20.2 million in 2021 and averaged $19.8 million.
  • Data for Legend Biotech's Share-based Compensation shows a peak YoY skyrocketed of 323.49% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Legend Biotech's Share-based Compensation stood at $4.8 million in 2020, then spiked by 323.49% to $20.2 million in 2021, then surged by 70.34% to $34.3 million in 2022.